Edgestream Partners’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.4M | Sell |
111,144
-47,964
| -30% | -$1.03M | 0.07% | 488 |
|
|
2025
Q1 | $2.64M | Sell |
159,108
-105,282
| -40% | -$1.75M | 0.09% | 417 |
|
|
2024
Q4 | $4.85M | Buy |
264,390
+45,061
| +21% | +$827K | 0.21% | 165 |
|
|
2024
Q3 | $3.37M | Buy |
219,329
+128,372
| +141% | +$1.97M | 0.15% | 232 |
|
|
2024
Q2 | $1.48M | Buy |
90,957
+29,051
| +47% | +$472K | 0.07% | 423 |
|
|
2024
Q1 | $1.14M | Buy |
61,906
+23,998
| +63% | +$444K | 0.06% | 467 |
|
|
2023
Q4 | $1.19M | Buy |
37,908
+28,205
| +291% | +$883K | 0.09% | 390 |
|
|
2023
Q3 | $202K | Sell |
9,703
-74,467
| -88% | -$1.55M | 0.02% | 786 |
|
|
2023
Q2 | $2.02M | Buy |
+84,170
| New | +$2.02M | 0.18% | 189 |
|